Company intelligence / Profile preview

Windfall Bio

Menlo Park / San Mateo, California, United Stateswindfall.bio ↗

Ownership: Private
Employees: ~50
Development stage: Commercial

Overview

Windfall Bio has developed and deployed the first-ever solution to capture and transform climate-harming methane emissions into organic fertilizer using methane-eating microbes. The company has achieved commercial-scale production of its "mems", received OMRI certification for its organic fertilizer product, and successfully piloted bio-reactors with food retailers. It is now scaling up deployments in landfill operations and expanding production capacity through fermentation partnerships.

Therapeutic areas: Metabolic DisordersOther
Modalities: Microbial therapyLive biotherapeutic product therapy
Industry: Non-Drug Biotech

Partnerships

Fermentation businesses for expanded production capacity

Beyond the preview

Go deeper on Windfall Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Windfall Bio.

Explore the full profile